Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 67,431 | 64,745 | 52,024 | 57,380 | 40,868 |
| Cost of Goods | 34,156 | 33,312 | 27,430 | 28,993 | 20,180 |
| Gross Profit | 33,275 | 31,433 | 24,594 | 28,387 | 20,689 |
| Operating Expenses | 25,507 | 23,361 | 17,851 | 27,739 | 25,529 |
| Operating Income | 7,924 | 8,384 | 7,173 | 1,641 | -4,661 |
| Interest Expense | 917 | 765 | 313 | 104 | 7 |
| Other Income | 133 | 14 | -699 | 811 | 1,249 |
| Pre-tax Income | 7,140 | 7,633 | 6,161 | 2,348 | -3,419 |
| Income Tax | 899 | 3,115 | 2,542 | 1,611 | 1,790 |
| Net Income Continuous | 6,241 | 4,518 | 3,619 | 737 | -5,208 |
| Net Income Discontinuous | -38,118 | -2,189 | 641 | N/A | N/A |
| Net Income | $-31,877 | $2,329 | $4,260 | $737 | $-5,208 |
| EPS Basic Total Ops | -10.50 | 0.80 | 1.40 | 0.30 | -2.00 |
| EPS Basic Continuous Ops | 2.00 | 1.50 | 1.20 | 0.27 | -2.02 |
| EPS Basic Discontinuous Ops | -12.50 | -0.70 | 0.20 | N/A | N/A |
| EPS Diluted Total Ops | -10.50 | 0.70 | 1.40 | 0.30 | -2.00 |
| EPS Diluted Continuous Ops | 2.00 | 1.50 | 1.20 | 0.27 | -2.02 |
| EPS Diluted Discontinuous Ops | -12.40 | -0.80 | 0.20 | N/A | N/A |
| EBITDA(a) | $12,961 | $14,730 | $12,462 | $4,651 | $-1,690 |